An Interview with MiraxBioPharma’s CEO
MiraxBioPharma unveils new logo and brand identity
Contact us
Pharmacovigilance
MiraxBioPharma is committed to ensuring the quality and safety of its products and pays special attention to collecting and analyzing information about adverse reactions and complaints associated with the use of our products.
If you become aware of any adverse reactions to the medicinal product Cezarox® Epi or of a lack of therapeutic effect, please report it via email at: adversareaction@drugsafety.ru or by phone: +7 (800) 777-86-04.
If you become aware of any adverse reactions to other MiraxBioPharma medicinal products or of a lack of therapeutic effect, please report it via email at: GVP@mbpharma.ru, by phone: +7 (495) 721-20-58 or by filling out the electronic form below
Preferred method of contact*
Change text from Agreement option in Settings
